12th Annual Project and Portfolio Management for Pharma

The pharma industry is under immense budget pressures that companies start scrutinising new projects. Coupled with patent cliff, undoubtedly, will have tremendous adverse impacts on the company’s portfolio and sustainability. At the same time, in order to stay competitive within the industry, pharma needs to be alerted of what their peers are doing, where the market gap is, how to develop a new robust PPM system to prevent project delay and overhead costs, as well as increasing their success rates and hence the ultimate return on investment.

 

This marcus evans conference provides invaluable knowledge to enhance your project and portfolio management strategies. Attendees will receive key industry insight into analytical tools for evaluating projects. Companies can learn from practical case studies on how to assess their portfolios, analyse project risks, how to continue business growth through in-licensing business partnerships and how to benchmark their portfolio of projects to enable tracking of project progress.